That being said, I'm going off the preliminary study that shows that vaccine >= infection for older variants whereas vaccine + infection >> vaccine for omicron.
As an aside, I've got three shots of Moderna in me and I caught omicron during the covidtastrophe a few weeks ago. It was extremely mild but I'm now resigned to the idea that vaccines are an assurance against getting actually sick more than a silver bullet.
More exposure basically means broader protection-- whether it's exposure through infection, vaccination, etc.
Whatever you're exposed to, the compliment and quantity of antibodies widens and is drawn towards whatever you're exposed to. You end up with antibodies that bind against whatever you're exposed to in many different ways-- many of which will be cross-reactive against other variants.
Obviously, it'd be nice if we had a omicron-based booster, because it would be broadening the protection more in that direction.
> As an aside, I've got three shots of Moderna in me and I caught omicron during the covidtastrophe a few weeks ago.
Sorry to hear that. We still have relatively little data, but it looks our best current guesses are:
* Vs. Delta: 2 doses of Pfizer/Moderna: about 60-70% effective against infection, 80-90% effective against symptoms, and 95%+ effective against severe illness.
* Vs. Omicron: 2 doses of Pfizer/Moderna: ???% (poor) effective against infection, 30% effective against symptoms, 50-70% effective against severe illness. 3 doses of Pfizer/Moderna: ???% (maybe moderate) efficacy against infection, 60%??? effective against symptoms (evidence quality poor), 85% effective against severe illness. It also looks like this is short lived and sloping down relatively fast.
In any case, you're protected every step of the way: Less likely to become infected, less likely to become symptomatic if infected, and less likely to develop severe illness if symptomatic.
One interesting epidemiological question is: vaccinated people are pretty likely to be asymptomatic with Omicron, so they may be more likely to spread it.
On the other hand, these "leaky vaccines" have already prevented a massive amount of mortality. Yes, the duration and quality of protection, even boosted, against Omicron is unfortunate... but even 2 doses can still be expected to save a high number of lives from Omicron.
Here's also some analysis about this effect with Omicron, which seems honest about the limitations: https://boriquagato.substack.com/p/theres-something-antigeni...
This is not supported by any evidence.
I can't believe this is your actual position. It's so wild I have to believe you're trolling. Even Paul Offit would agree.
(4 in 18 months with boosters every decade)
Are you up to date on your boosters for DPT? I don't know anyone who has maintained that.
This may be a factor. But, repeated exposure means more breadth of antibodies. B cells aggressively replicate and mutate in response to pathogens, and those that match are selected for. Repeating this process gets more B cells, but also broader varieties of resultant antibodies matching not just the original pathogen but things that are close to it. This is why:
* 1 dose of mRNA was pretty effective against B.1.1.7, but not very effective against Delta, which had some immune escape mutations.
* 2 doses of mRNA vaccines targeted at B.1.1.7 were pretty effective against Delta, but only slightly effective against Omicron, which had a lot of (different) immune escape mutations.
* 3 doses of mRNA vaccines targeted at B.1.1.7 seem pretty effective against Omicron.